367 related articles for article (PubMed ID: 25927679)
1. Cellular and molecular mechanisms of statins: an update on pleiotropic effects.
Satoh M; Takahashi Y; Tabuchi T; Minami Y; Tamada M; Takahashi K; Itoh T; Morino Y; Nakamura M
Clin Sci (Lond); 2015 Jul; 129(2):93-105. PubMed ID: 25927679
[TBL] [Abstract][Full Text] [Related]
2. Toward immunomodulatory and anti-inflammatory properties of statins.
Arnaud C; Braunersreuther V; Mach F
Trends Cardiovasc Med; 2005 Aug; 15(6):202-6. PubMed ID: 16182129
[TBL] [Abstract][Full Text] [Related]
3. Statins and myocardial infarction: Type, dose, and administration time: Does it matter?
Papageorgiou N; Zacharia E; Briasoulis A; Androulakis E; Tousoulis D
Trends Cardiovasc Med; 2016 Jul; 26(5):433-41. PubMed ID: 26948202
[TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia Part 2: Review of Dyslipidemia Treatment in Patients With Noncoronary Vascular Disease.
Gonzalez L; Helkin A; Gahtan V
Vasc Endovascular Surg; 2016 Feb; 50(2):119-35. PubMed ID: 26983668
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis: can statins play a dual role?
Rajpara AN; Goldner R; Gaspari A
Dermatol Online J; 2010 Feb; 16(2):2. PubMed ID: 20178698
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
[TBL] [Abstract][Full Text] [Related]
7. Pleiotropic effects of statins: new therapeutic targets in drug design.
Bedi O; Dhawan V; Sharma PL; Kumar P
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):695-712. PubMed ID: 27146293
[TBL] [Abstract][Full Text] [Related]
8. Activation of sphingosine-1-phosphate signalling as a potential underlying mechanism of the pleiotropic effects of statin therapy.
Egom EE; Rose RA; Neyses L; Soran H; Cleland JG; Mamas MA
Crit Rev Clin Lab Sci; 2013; 50(3):79-89. PubMed ID: 23885725
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.
Kratzer A; Giral H; Landmesser U
Cardiovasc Res; 2014 Aug; 103(3):350-61. PubMed ID: 24935432
[TBL] [Abstract][Full Text] [Related]
10. Statins and prevention of venous thromboembolism: Myth or reality?
Gaertner S; Cordeanu EM; Nouri S; Mirea C; Stephan D
Arch Cardiovasc Dis; 2016 Mar; 109(3):216-22. PubMed ID: 26778087
[TBL] [Abstract][Full Text] [Related]
11. [The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes].
Cecha J; Drabek G; Błazelonis A; Romanowski W; Zubelewicz-Szkodzińska B
Wiad Lek; 2004; 57(5-6):255-8. PubMed ID: 15518071
[TBL] [Abstract][Full Text] [Related]
12. Primary and Secondary Prevention of Acute Coronary Syndromes: The Role of the Statins.
Diamantis E; Troupis T; Mazarakis A; Kyriakos G; Diamanti S; Troupis G; Skandalakis P
Recent Adv Cardiovasc Drug Discov; 2014; 9(2):97-105. PubMed ID: 26152179
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
Danesh FR; Kanwar YS
FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
[TBL] [Abstract][Full Text] [Related]
14. The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis.
Blum A; Shamburek R
Atherosclerosis; 2009 Apr; 203(2):325-30. PubMed ID: 18834985
[TBL] [Abstract][Full Text] [Related]
15. The Pleiotropic Effects of Statins - From Coronary Artery Disease and Stroke to Atrial Fibrillation and Ventricular Tachyarrhythmia.
Oesterle A; Liao JK
Curr Vasc Pharmacol; 2019; 17(3):222-232. PubMed ID: 30124154
[TBL] [Abstract][Full Text] [Related]
16. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
Marzilli M
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
[TBL] [Abstract][Full Text] [Related]
17. Residual risk and high-density lipoprotein cholesterol levels: is there a relationship?
Shah PK
Rev Cardiovasc Med; 2011; 12(2):e55-9. PubMed ID: 21796083
[TBL] [Abstract][Full Text] [Related]
18. Do statins have a role in reduction/prevention of post-PCI restenosis?
Prasad K
Cardiovasc Ther; 2013 Feb; 31(1):12-26. PubMed ID: 21967674
[TBL] [Abstract][Full Text] [Related]
19. Drug-induced immunomodulation to affect the development and progression of atherosclerosis: a new opportunity?
Heeneman S; Donners MM; Bai L; Daemen MJ
Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):345-64. PubMed ID: 17338677
[TBL] [Abstract][Full Text] [Related]
20. Statins and the endothelium.
Ii M; Losordo DW
Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
